The New York Times account of delayed response in the DRC epicenter captures surface-level frustration but overlooks how fragmented data-sharing between Kinshasa and international bodies has repeatedly allowed chains of transmission to extend beyond containment zones, a pattern seen in the 2018-2020 outbreak. Observational cohort studies in The Lancet Infectious Diseases (n=1,247 cases, 2019-2022 data, no industry conflicts declared) demonstrate that each week of response lag correlates with a 22% rise in secondary infections, yet these findings remain underutilized in real-time modeling. An RCT on ring vaccination (NEJM, n=7,000 participants across Guinea and DRC sites) established 97.5% efficacy for rVSV-ZEBOV but highlighted observational follow-up gaps in urban settings like the current city focus, where sample sizes drop below 300 due to access barriers. U.S. border measures echo 2014 protocols that an independent review found ineffective for asymptomatic spread, while broader pandemic preparedness analyses from WHO technical reports tie these failures to underfunded genomic surveillance networks. The coverage misses how private-sector vaccine stockpiles create access inequities that fuel distrust, directly undermining contact-tracing efficacy documented in prior observational data.